
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12746710
[patent_doc_number] => 20180140737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => HAEMOSTATIC MATERIAL
[patent_app_type] => utility
[patent_app_number] => 15/572908
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15572908
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/572908 | HAEMOSTATIC MATERIAL | May 10, 2016 | Abandoned |
Array
(
[id] => 17280901
[patent_doc_number] => 11197914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => GLP-1R/GCGR dual target agonist polypeptide for treatment of fatty liver diseases, hyperlipemia and arteriosclerosis
[patent_app_type] => utility
[patent_app_number] => 16/089228
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 6960
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089228
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089228 | GLP-1R/GCGR dual target agonist polypeptide for treatment of fatty liver diseases, hyperlipemia and arteriosclerosis | May 10, 2016 | Issued |
Array
(
[id] => 11040162
[patent_doc_number] => 20160237118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'LEUKEMIA STEM CELL TARGETING LIGANDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/142912
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21592
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/142912 | Leukemia stem cell targeting ligands and methods of use | Apr 28, 2016 | Issued |
Array
(
[id] => 14820963
[patent_doc_number] => 10407473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Methods for treating disorders that involve immunoglobulin A
[patent_app_type] => utility
[patent_app_number] => 15/139710
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13873
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15139710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/139710 | Methods for treating disorders that involve immunoglobulin A | Apr 26, 2016 | Issued |
Array
(
[id] => 11034384
[patent_doc_number] => 20160231340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/137705
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10223
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137705
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/137705 | Ultra-small apoB-containing particles and methods of use thereof | Apr 24, 2016 | Issued |
Array
(
[id] => 14088079
[patent_doc_number] => 10239933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-26
[patent_title] => Compositions and methods for modulating thrombin generation
[patent_app_type] => utility
[patent_app_number] => 15/131385
[patent_app_country] => US
[patent_app_date] => 2016-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 28
[patent_no_of_words] => 10777
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/131385 | Compositions and methods for modulating thrombin generation | Apr 17, 2016 | Issued |
Array
(
[id] => 11025104
[patent_doc_number] => 20160222058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/131662
[patent_app_country] => US
[patent_app_date] => 2016-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10545
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131662
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/131662 | BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME | Apr 17, 2016 | Abandoned |
Array
(
[id] => 12702274
[patent_doc_number] => 20180125924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => SUPRAMOLECULAR GLYCOSAMINOGLYCANS
[patent_app_type] => utility
[patent_app_number] => 15/566066
[patent_app_country] => US
[patent_app_date] => 2016-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566066 | Supramolecular gylcosaminoglycans | Apr 12, 2016 | Issued |
Array
(
[id] => 14454253
[patent_doc_number] => 10323078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 15/559984
[patent_app_country] => US
[patent_app_date] => 2016-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 32
[patent_no_of_words] => 18340
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559984 | Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases | Mar 20, 2016 | Issued |
Array
(
[id] => 15309659
[patent_doc_number] => 10519521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Method of preventing carbohydrate crystallization
[patent_app_type] => utility
[patent_app_number] => 15/067012
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 22
[patent_no_of_words] => 6516
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15067012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/067012 | Method of preventing carbohydrate crystallization | Mar 9, 2016 | Issued |
Array
(
[id] => 11129241
[patent_doc_number] => 20160326217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'Methods and Compositions Related to Cyclic Peptide Synthesis'
[patent_app_type] => utility
[patent_app_number] => 15/061723
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 38516
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061723 | Methods and Compositions Related to Cyclic Peptide Synthesis | Mar 3, 2016 | Abandoned |
Array
(
[id] => 10820418
[patent_doc_number] => 20160166582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'PROTEASOME INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/050502
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15815
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050502 | PROTEASOME INHIBITORS AND USES THEREOF | Feb 22, 2016 | Abandoned |
Array
(
[id] => 10978457
[patent_doc_number] => 20160175399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'IL-13 RECEPTOR BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/045557
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9481
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045557
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/045557 | IL-13 receptor binding peptides | Feb 16, 2016 | Issued |
Array
(
[id] => 15663781
[patent_doc_number] => 10596095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Method for moisturizing skin using P-113 peptide
[patent_app_type] => utility
[patent_app_number] => 15/550030
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3993
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550030 | Method for moisturizing skin using P-113 peptide | Feb 3, 2016 | Issued |
Array
(
[id] => 12138230
[patent_doc_number] => 20180016313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'MODIFIED DKK2 PROTEIN, NUCLEIC ACID ENCODING THE SAME, PREPARATION METHOD THEREOF, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/548580
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7774
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548580 | Modified DKK2 protein, nucleic acid encoding the same, preparation method thereof, and use thereof | Feb 2, 2016 | Issued |
Array
(
[id] => 15604355
[patent_doc_number] => 10583218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Composite containing collagen and elastin as a dermal expander and tissue filler
[patent_app_type] => utility
[patent_app_number] => 15/012257
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 12318
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012257
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012257 | Composite containing collagen and elastin as a dermal expander and tissue filler | Jan 31, 2016 | Issued |
Array
(
[id] => 16696701
[patent_doc_number] => 10947282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Functionalized protein-based materials and their uses
[patent_app_type] => utility
[patent_app_number] => 15/544216
[patent_app_country] => US
[patent_app_date] => 2016-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3003
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544216 | Functionalized protein-based materials and their uses | Jan 19, 2016 | Issued |
Array
(
[id] => 11009750
[patent_doc_number] => 20160206703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/996800
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8793
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/996800 | METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS | Jan 14, 2016 | Abandoned |
Array
(
[id] => 11011284
[patent_doc_number] => 20160208237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY'
[patent_app_type] => utility
[patent_app_number] => 14/991823
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7995
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991823
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/991823 | Modifications of peptide compositions to increase stability and delivery efficiency | Jan 7, 2016 | Issued |
Array
(
[id] => 13714281
[patent_doc_number] => 20170368095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => MAGNESIUM-CONTAINING OXYTOCIN FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/541991
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541991
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541991 | Magnesium-containing oxytocin formulations and methods of use | Jan 6, 2016 | Issued |